SOPHiA GENETICS (SOPH) CMO Philippe Menu Sells 5,000 Shares

What Happened
Philippe Menu, Chief Medical Officer of SOPHiA GENETICS SA, sold 5,000 shares on July 27, 2026. The weighted-average price reported was $5.66 per share for total proceeds of approximately $28,306. This was a sale (disposition) executed as an open-market/private sale (Code S).

Key Details

• Transaction date: 2026-07-27; filing date: 2026-07-28 (no late filing indicated).
• Reported weighted-average price: $5.66 per share; shares sold in multiple trades at prices ranging from $5.57 to $5.83 (footnote F2).
• Total proceeds: ~$28,306.
• Shares owned after the transaction: not specified in the Form 4 filing.
• Footnotes: F1 — trade executed pursuant to a Rule 10b5-1(c) trading plan; F2 — weighted average price and offer to provide per-price breakdown on request.
• Transaction type: Sale (Code S); not an option exercise, gift, or award.

Context
Sales by insiders are common and do not by themselves indicate a change in company fundamentals. The trade was executed under a pre-established 10b5-1 plan (per F1), which typically means the transaction was preplanned and may limit inference about the insider’s current view of the company. Retail investors who track insider activity may treat preplanned sales as less informative than discretionary purchases.